vs
Kymera Therapeutics, Inc.（KYMR）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
Kymera Therapeutics, Inc.的季度营收约是Rocky Mountain Chocolate Factory, Inc.的1.5倍（$11.5M vs $7.5M），Rocky Mountain Chocolate Factory, Inc.净利率更高（-2.1% vs -667.6%，领先665.5%），Rocky Mountain Chocolate Factory, Inc.同比增速更快（-4.4% vs -55.3%），Rocky Mountain Chocolate Factory, Inc.自由现金流更多（$-1.3M vs $-60.6M），过去两年Kymera Therapeutics, Inc.的营收复合增速更高（10.1% vs 1.9%）
Kymera Therapeutics是一家处于临床阶段的生物制药企业，专注开发创新靶向蛋白降解疗法，推进覆盖肿瘤、自身免疫、炎症类疾病领域的多元化管线，旨在攻克此前无法成药的靶点，满足全球范围的未被满足的医疗需求。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
KYMR vs RMCF — 直观对比
损益表 — Q2 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $11.5M | $7.5M |
| 净利润 | $-76.6M | $-155.0K |
| 毛利率 | — | 34.0% |
| 营业利润率 | -736.8% | 1.1% |
| 净利率 | -667.6% | -2.1% |
| 营收同比 | -55.3% | -4.4% |
| 净利润同比 | -82.1% | 81.7% |
| 每股收益（稀释后） | $-0.95 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $7.5M | ||
| Q3 25 | — | $6.8M | ||
| Q2 25 | $11.5M | $6.4M | ||
| Q1 25 | $22.1M | $8.9M | ||
| Q4 24 | $7.4M | $7.9M | ||
| Q3 24 | — | $6.4M | ||
| Q2 24 | $25.6M | $6.4M | ||
| Q1 24 | $10.3M | $7.3M |
| Q4 25 | — | $-155.0K | ||
| Q3 25 | — | $-662.0K | ||
| Q2 25 | $-76.6M | $-324.0K | ||
| Q1 25 | $-65.6M | $-2.9M | ||
| Q4 24 | $-70.8M | $-847.0K | ||
| Q3 24 | — | $-722.0K | ||
| Q2 24 | $-42.1M | $-1.7M | ||
| Q1 24 | $-48.6M | $-1.6M |
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 23.6% | ||
| Q2 25 | — | 31.1% | ||
| Q1 25 | — | 10.8% | ||
| Q4 24 | — | 23.4% | ||
| Q3 24 | — | 31.8% | ||
| Q2 24 | — | 12.8% | ||
| Q1 24 | — | 24.3% |
| Q4 25 | — | 1.1% | ||
| Q3 25 | — | -7.0% | ||
| Q2 25 | -736.8% | -2.3% | ||
| Q1 25 | -336.8% | -30.3% | ||
| Q4 24 | -1092.2% | -8.9% | ||
| Q3 24 | — | -14.3% | ||
| Q2 24 | -198.5% | -25.4% | ||
| Q1 24 | -562.2% | -21.7% |
| Q4 25 | — | -2.1% | ||
| Q3 25 | — | -9.7% | ||
| Q2 25 | -667.6% | -5.1% | ||
| Q1 25 | -296.7% | -32.5% | ||
| Q4 24 | -956.9% | -10.7% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | -164.0% | -25.9% | ||
| Q1 24 | -472.0% | -21.9% |
| Q4 25 | — | $-0.02 | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | $-0.95 | $-0.04 | ||
| Q1 25 | $-0.82 | $-0.38 | ||
| Q4 24 | $-0.89 | $-0.11 | ||
| Q3 24 | — | $-0.11 | ||
| Q2 24 | $-0.58 | $-0.26 | ||
| Q1 24 | $-0.69 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $335.8M | $641.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $971.5M | $6.0M |
| 总资产 | $1.1B | $20.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $641.0K | ||
| Q3 25 | — | $2.0M | ||
| Q2 25 | $335.8M | $893.0K | ||
| Q1 25 | $90.0M | $720.0K | ||
| Q4 24 | $120.3M | $1.1M | ||
| Q3 24 | — | $973.0K | ||
| Q2 24 | $67.6M | $637.0K | ||
| Q1 24 | $93.5M | $2.1M |
| Q4 25 | — | $6.0M | ||
| Q3 25 | — | $6.1M | ||
| Q2 25 | $971.5M | $6.7M | ||
| Q1 25 | $786.2M | $7.0M | ||
| Q4 24 | $835.6M | $9.8M | ||
| Q3 24 | — | $10.5M | ||
| Q2 24 | $684.9M | $9.0M | ||
| Q1 24 | $711.2M | $10.6M |
| Q4 25 | — | $20.7M | ||
| Q3 25 | — | $22.3M | ||
| Q2 25 | $1.1B | $20.1M | ||
| Q1 25 | $918.3M | $21.2M | ||
| Q4 24 | $978.0M | $21.6M | ||
| Q3 24 | — | $21.1M | ||
| Q2 24 | $826.0M | $19.0M | ||
| Q1 24 | $868.3M | $20.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-59.9M | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | $-60.6M | $-1.3M |
| 自由现金流率自由现金流/营收 | -527.9% | -16.9% |
| 资本支出强度资本支出/营收 | 6.1% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-250.5M | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $-1.2M | ||
| Q3 25 | — | $-488.0K | ||
| Q2 25 | $-59.9M | $350.0K | ||
| Q1 25 | $-79.2M | $1.2M | ||
| Q4 24 | $-61.8M | $-2.1M | ||
| Q3 24 | — | $-3.5M | ||
| Q2 24 | $-42.9M | $-2.2M | ||
| Q1 24 | $-39.6M | $129.0K |
| Q4 25 | — | $-1.3M | ||
| Q3 25 | — | $-544.0K | ||
| Q2 25 | $-60.6M | $182.0K | ||
| Q1 25 | $-79.6M | — | ||
| Q4 24 | $-62.7M | — | ||
| Q3 24 | — | $-4.6M | ||
| Q2 24 | $-47.6M | $-2.6M | ||
| Q1 24 | $-47.0M | $-352.3K |
| Q4 25 | — | -16.9% | ||
| Q3 25 | — | -8.0% | ||
| Q2 25 | -527.9% | 2.9% | ||
| Q1 25 | -360.3% | — | ||
| Q4 24 | -848.3% | — | ||
| Q3 24 | — | -72.6% | ||
| Q2 24 | -185.7% | -40.2% | ||
| Q1 24 | -456.8% | -4.9% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | 6.1% | 2.6% | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 12.7% | — | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | 18.3% | 6.5% | ||
| Q1 24 | 72.0% | 6.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KYMR
暂无分部数据
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
